within Pharmacolibrary.Drugs.ATC.C;

model C10AX02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.05,
    Cl             = 0.0002883333333333333,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.41,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0023333333333333335,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C10AX02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Probucol is a lipid-lowering agent previously used to reduce serum cholesterol and low-density lipoprotein (LDL) levels. It is a bisphenol antioxidant that was indicated primarily for the treatment of hypercholesterolemia and prevention of atherosclerosis. Due to concerns regarding adverse effects, including QT interval prolongation and proarrhythmic potential, its use has been discontinued in many countries, and it is not widely approved or used today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for healthy adult volunteers after repeated oral dosing.</p><h4>References</h4><ol><li><p>Jeon, H, et al., &amp; Yu, KS (2011). Pharmacokinetics and tolerability of probucol after multiple oral administrations in healthy volunteers. <i>International journal of clinical pharmacology and therapeutics</i> 49(11) 688–695. DOI:<a href=&quot;https://doi.org/10.5414/cp201525&quot;>10.5414/cp201525</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22011694/&quot;>https://pubmed.ncbi.nlm.nih.gov/22011694</a></p></li><li><p>Li, J, et al., &amp; Wang, S (2017). Improved oral bioavailability of probucol by dry media-milling. <i>Materials science &amp; engineering. C, Materials for biological applications</i> 78 780–786. DOI:<a href=&quot;https://doi.org/10.1016/j.msec.2017.04.141&quot;>10.1016/j.msec.2017.04.141</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28576049/&quot;>https://pubmed.ncbi.nlm.nih.gov/28576049</a></p></li><li><p>Heeg, JF, et al., &amp; Rose, JQ (1984). Pharmacokinetics of probucol in male rats. <i>Journal of pharmaceutical sciences</i> 73(12) 1758–1763. DOI:<a href=&quot;https://doi.org/10.1002/jps.2600731225&quot;>10.1002/jps.2600731225</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6527251/&quot;>https://pubmed.ncbi.nlm.nih.gov/6527251</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C10AX02;
